Nadezhda Ivanovna Rozhkova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nadezhda Ivanovna Rozhkova has a total of 150 co-authors. Here are the top co-authors by number of shared publications:
G. P. Kochetova
Ministry of Health of the Russian Federation
16 shared publications- Михаил Львович Мазо
National Medical Research Center for Therapy and Preventive Medicine
14 shared publications E. G. Chikirdin
Ministry of Health of the Russian Federation
9 shared publications- Andrei Dmitrievich Kaprin
National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation, Koroleva St. 4, 249036 Obninsk, Russia
8 shared publications - S. Yu. Mikushin
National Medical Research Center for Therapy and Preventive Medicine
8 shared publications - Sergey Prokopenko
National Medical Research Center for Therapy and Preventive Medicine
8 shared publications
Latest Publications
- 14 October 2026
- Published by Media Sphere Publishing Group in Russian Journal of Preventive Medicine
- Vol. 29 (9)
Awareness and attitudes of Russian physicians about breast arterial calcification — a new marker of cardiovascular risk in women
Objective. To evaluate the awareness of Russian radiologists and referring physicians concerning the clinical significance of breast arterial calcification (BAC), and to examine their perspectives on the necessity and approaches for informing women who have undergone mammography about BAC. Materials and methods. An anonymous survey was administered to 103 Russian radiologists, mammologists, oncologists, obstetrician-gynecologists, and therapists. The 24-item questionnaire collected information on demographics, work experience, type of medical organization, awareness of the association between BAC and cardiovascular disease (CVD) risk, practices related to informing patients about BAC, respondents’ opinions on BAC, and subsequent patient routing. Results. A total of 47.6% of respondents reported awareness of the association between BAC and CVD. Radiologists exhibited significantly greater awareness compared to other physician groups (p=0.036). Higher awareness was also found among those dedicating more than 25% of their working time to imaging, interpreting over 100 images annually, and participating in screening mammogram interpretation (p=0.006, p=0.008, and p=0.025, respectively). No significant association was observed between awareness and gender, age, region of residence, position, or type of medical organization. BAC was documented in imaging reports by 57.6% of physicians, of whom 39.5% either referred patients to a therapist or provided recommendations. The binary classification of BAC was used by 84.2% of physicians. In total, 80.6% of respondents indicated that information about identified BAC should be included in the report conclusion. Conclusion. This study is the first to show that Russian physicians have limited awareness of the association between BAC and increased CVD risk. Experienced radiologists are more likely to recognize the prognostic significance of BAC. Most respondents prefer a binary classification of BAC and consider it essential to document it in the report conclusion.
- 14 October 2026
- Published by Media Sphere Publishing Group in Russian Journal of Preventive Medicine
- Vol. 29 (9)
Awareness and attitudes of Russian physicians about breast arterial calcification — a new marker of cardiovascular risk in women
Objective. To evaluate the awareness of Russian radiologists and referring physicians concerning the clinical significance of breast arterial calcification (BAC), and to examine their perspectives on the necessity and approaches for informing women who have undergone mammography about BAC. Materials and methods. An anonymous survey was administered to 103 Russian radiologists, mammologists, oncologists, obstetrician-gynecologists, and therapists. The 24-item questionnaire collected information on demographics, work experience, type of medical organization, awareness of the association between BAC and cardiovascular disease (CVD) risk, practices related to informing patients about BAC, respondents’ opinions on BAC, and subsequent patient routing. Results. A total of 47.6% of respondents reported awareness of the association between BAC and CVD. Radiologists exhibited significantly greater awareness compared to other physician groups (p=0.036). Higher awareness was also found among those dedicating more than 25% of their working time to imaging, interpreting over 100 images annually, and participating in screening mammogram interpretation (p=0.006, p=0.008, and p=0.025, respectively). No significant association was observed between awareness and gender, age, region of residence, position, or type of medical organization. BAC was documented in imaging reports by 57.6% of physicians, of whom 39.5% either referred patients to a therapist or provided recommendations. The binary classification of BAC was used by 84.2% of physicians. In total, 80.6% of respondents indicated that information about identified BAC should be included in the report conclusion. Conclusion. This study is the first to show that Russian physicians have limited awareness of the association between BAC and increased CVD risk. Experienced radiologists are more likely to recognize the prognostic significance of BAC. Most respondents prefer a binary classification of BAC and consider it essential to document it in the report conclusion.
- Open Access
- 15 September 2026
- Published by Autonomous non-profit scientific and medical organization - Questions of Oncology in Voprosy onkologii
- Vol. 72 (4) , 2465
Evaluation of Artificial Intelligence Effectiveness in Multimodal Diagnosis and Prediction of Response to Drug Therapy in Different Biological Subtypes of Breast Cancer (Literature Review)
Одно из ключевых направлений в борьбе с раком молочной железы (РМЖ), который остается самым распространенным онкологическим заболеванием у женщин в мире, связано с ранним выявлением новообразований, их правильной интерпретацией и установлением факторов, определяющих выбор оптимальной тактики лечения. В свою очередь, сложившиеся «медицинские» реалии в контексте располагаемых человеческих ресурсов, имеющихся нормативов и необходимости обрабатывать гигантские объемы исследований диктуют необходимость поиска новых эффективных инструментариев диагностики РМЖ. В этой связи интеграция в процесс лучевой диагностики РМЖ высокопроизводительных технологий на базе искусственного интеллекта (ИИ) представляется чрезвычайно важной и актуальной. Интерес к этой теме находит отражение во все возрастающем числе научных публикаций, число которых за последние шесть лет увеличилось в четыре раза. На этом фоне отсутствие полноценного внедрения результатов исследований в повседневную, полномасштабную клиническую практику мотивирует к изучению состояния данного вопроса на предмет оценки итоговых результатов научной деятельности и понимания ее потенциальных перспектив. Настоящее исследование направлено на структурирование и систематизацию данных научной литературы, освещающих вопросы применения математических моделей ИИ для анализа традиционной и мультимодальной визуализации новообразований в молочной железе при определении молекулярно-биологического подтипа РМЖ, оценки ответа опухоли на лекарственное лечение, других аспектов диагностики РМЖ, ориентирующих на персонифицированный подход к прогнозированию, планированию и лечению пациента. Проанализированы наиболее широко применяемые и перспективные модели и алгоритмы обучения нейронных сетей, используемые в последнее время, определены их потенциальные возможности для выработки единых подходов к интеграции ИИ в арсенал средств автоматизации процесса мультимодальной диагностики РМЖ. Результаты проведенной работы позволили сформулировать основные тренды проводимых научных исследований, косвенно оценить их потенциальную эффективность в решении вопросов прогнозирования сценариев диагностики и лечения РМЖ.
- 15 September 2026
- Published by Autonomous non-profit scientific and medical organization - Questions of Oncology in Voprosy onkologii
- Vol. 72 (4) , 2465
Open AccessEvaluation of Artificial Intelligence Effectiveness in Multimodal Diagnosis and Prediction of Response to Drug Therapy in Different Biological Subtypes of Breast Cancer (Literature Review)
Одно из ключевых направлений в борьбе с раком молочной железы (РМЖ), который остается самым распространенным онкологическим заболеванием у женщин в мире, связано с ранним выявлением новообразований, их правильной интерпретацией и установлением факторов, определяющих выбор оптимальной тактики лечения. В свою очередь, сложившиеся «медицинские» реалии в контексте располагаемых человеческих ресурсов, имеющихся нормативов и необходимости обрабатывать гигантские объемы исследований диктуют необходимость поиска новых эффективных инструментариев диагностики РМЖ. В этой связи интеграция в процесс лучевой диагностики РМЖ высокопроизводительных технологий на базе искусственного интеллекта (ИИ) представляется чрезвычайно важной и актуальной. Интерес к этой теме находит отражение во все возрастающем числе научных публикаций, число которых за последние шесть лет увеличилось в четыре раза. На этом фоне отсутствие полноценного внедрения результатов исследований в повседневную, полномасштабную клиническую практику мотивирует к изучению состояния данного вопроса на предмет оценки итоговых результатов научной деятельности и понимания ее потенциальных перспектив. Настоящее исследование направлено на структурирование и систематизацию данных научной литературы, освещающих вопросы применения математических моделей ИИ для анализа традиционной и мультимодальной визуализации новообразований в молочной железе при определении молекулярно-биологического подтипа РМЖ, оценки ответа опухоли на лекарственное лечение, других аспектов диагностики РМЖ, ориентирующих на персонифицированный подход к прогнозированию, планированию и лечению пациента. Проанализированы наиболее широко применяемые и перспективные модели и алгоритмы обучения нейронных сетей, используемые в последнее время, определены их потенциальные возможности для выработки единых подходов к интеграции ИИ в арсенал средств автоматизации процесса мультимодальной диагностики РМЖ. Результаты проведенной работы позволили сформулировать основные тренды проводимых научных исследований, косвенно оценить их потенциальную эффективность в решении вопросов прогнозирования сценариев диагностики и лечения РМЖ.
- Open Access
- 3 July 2026
- Published by Autonomous non-profit scientific and medical organization - Questions of Oncology in Voprosy onkologii
- Vol. 72 (3)
Contrast-Enhanced Ultrasound for Precise Sentinel Lymph Node Mapping in Breast Cancer
Введение. Предоперационное стадирование рака молочной железы по статусу сигнальных лимфатических узлов традиционно выполняется радиоизотопными методами, которые сопряжены с лучевой нагрузкой, необходимостью специализированной инфраструктуры и риском аллергических реакций. Контрастно-усиленное ультразвуковое исследование выступает перспективной альтернативой, однако его широкое клиническое применение ограничено отсутствием унифицированных протоколов визуализации и недостаточной изученностью анатомо-клинических факторов, влияющих на точность картирования лимфатического русла. Цель. Оптимизация методики поиска сигнальных лимфатических узлов с помощью контрастно-усиленного ультразвукового исследования с определением показаний и ограничений метода. Материалы и методы. В исследование включены 30 пациенток с верифицированным раком молочной железы стадии cT1–2N0M0. Всем больным выполнялось контрастно-усиленное ультразвуковое исследование с субареолярным введением микропузырькового контрастного препарата. В качестве контрольного метода использовалась предоперационная радионуклидная визуализация, а также гистологическое заключение постоперационного материала. Результаты. Визуализация лимфатических сосудов достигнута в 100 % случаев, сигнальных лимфатических узлов — в 90 %. Совпадение локализации сигнальных лимфатических узлов с радионуклидным методом составило 83,3 %. Выводы. Контрастно-усиленное ультразвуковое исследование является перспективным методом визуализации сигнальных лимфатических узлов, обладающим высокой диагностической ценностью с благоприятным профилем безопасности, однако для внедрения в предоперационный алгоритм обследования требуется дальнейшая стандартизация протокола и валидация в многоцентровых исследованиях.
- 3 July 2026
- Published by Autonomous non-profit scientific and medical organization - Questions of Oncology in Voprosy onkologii
- Vol. 72 (3)
Open AccessContrast-Enhanced Ultrasound for Precise Sentinel Lymph Node Mapping in Breast Cancer
Введение. Предоперационное стадирование рака молочной железы по статусу сигнальных лимфатических узлов традиционно выполняется радиоизотопными методами, которые сопряжены с лучевой нагрузкой, необходимостью специализированной инфраструктуры и риском аллергических реакций. Контрастно-усиленное ультразвуковое исследование выступает перспективной альтернативой, однако его широкое клиническое применение ограничено отсутствием унифицированных протоколов визуализации и недостаточной изученностью анатомо-клинических факторов, влияющих на точность картирования лимфатического русла. Цель. Оптимизация методики поиска сигнальных лимфатических узлов с помощью контрастно-усиленного ультразвукового исследования с определением показаний и ограничений метода. Материалы и методы. В исследование включены 30 пациенток с верифицированным раком молочной железы стадии cT1–2N0M0. Всем больным выполнялось контрастно-усиленное ультразвуковое исследование с субареолярным введением микропузырькового контрастного препарата. В качестве контрольного метода использовалась предоперационная радионуклидная визуализация, а также гистологическое заключение постоперационного материала. Результаты. Визуализация лимфатических сосудов достигнута в 100 % случаев, сигнальных лимфатических узлов — в 90 %. Совпадение локализации сигнальных лимфатических узлов с радионуклидным методом составило 83,3 %. Выводы. Контрастно-усиленное ультразвуковое исследование является перспективным методом визуализации сигнальных лимфатических узлов, обладающим высокой диагностической ценностью с благоприятным профилем безопасности, однако для внедрения в предоперационный алгоритм обследования требуется дальнейшая стандартизация протокола и валидация в многоцентровых исследованиях.
- 29 June 2026
- Published by "MedINK" Publishing House in Academy for Practical Oncology
- Vol. 1 (1)
The role of surface learning neural network in the study of primary multiple breast cancer
BACKGROUND: In recent decades, there has been an increase in the incidence of multiple malignancies. The incidence of this type of cancer ranges from 4.6 to 8.0 %. Subsequent tumors are detected between 1.5 and 42 years. The average interval between the primary and secondary processes is 6 years. More than 80 % of cases of primary multiple cancer (PMC) occur in people over 60 years of age. AIM: To generalize the patterns of development of PMC associated with breast cancer (BC), and to predict risk factors. METHODS: We retrospectively reviewed the medical records of 62 women with VUR, examined and treated at the Sverdlovsk Regional Oncology Center (Yekaterinburg) from 2020 to 2022. VUR associated with breast cancer was detected in 2 % of cases. Three women were excluded from the study according to the Warren–Gates criteria: two with metastases and one with mammary tuberculosis. The average time to secondary tumor detection was 5.4 years (range, 2 to 10 years). PMC was detected in the other breast in 29 % of cases, endometrial lesions were diagnosed in 17.7 % of patients, and malignant ovarian and renal neoplasms were diagnosed in 9.6 %. Disease progression in the form of metastases was observed in 14.5% of cases in patients over 55 years of age. Family history was a significant risk factor in 36 % of cases, gene mutations in 18.5 %, hormonal status in 49.4 %, obesity in 45.6 %, lymph node status in 48.4 %, previous treatment (chemotherapy or radiation therapy) in 5 %, and environmental factors in 24.5 %. A shallow learning neural network was used to predict risk factors for the development of PMC. The input data (diagnostic features) were converted to binary form: a value of “1” for a feature indicated its presence, a value of “0” indicated its absence. When training and testing the neural network, the target function was the time of secondary tumor onset and, in the presence of known breast cancer, also the time of progression. RESULTS: The risk of developing PMC within 5 years with a sensitivity of 86%, a specificity of 100 %, and an AUC of 0.929 (AUC – area under the receiver operating characteristic curve) was observed in patients over 60 years of age with stage T1–2N1 disease and luminal B and luminal/HER2-positive breast cancer (HER2 – human epidermal growth factor receptor 2). The development of PMC more than 5 years after the primary process, with a sensitivity of 64 %, a specificity of 86 %, and an AUC of 0.714, is possible in patients under 60 years of age with the luminal B molecular subtype of breast cancer and a primary tumor with a malignancy grade of G2. CONCLUSION: There is no consensus on the causes of PMC development (single tumors are not an exception). Increased survival after the onset of the first malignancy leads to an increased frequency of detection of second and subsequent tumors. Patients diagnosed with PMC, especially those with a strong family history and early onset of the disease, should be referred to a geneticist for consultation.
- 29 June 2026
- Published by "MedINK" Publishing House in Academy for Practical Oncology
- Vol. 1 (1)
The role of surface learning neural network in the study of primary multiple breast cancer
BACKGROUND: In recent decades, there has been an increase in the incidence of multiple malignancies. The incidence of this type of cancer ranges from 4.6 to 8.0 %. Subsequent tumors are detected between 1.5 and 42 years. The average interval between the primary and secondary processes is 6 years. More than 80 % of cases of primary multiple cancer (PMC) occur in people over 60 years of age. AIM: To generalize the patterns of development of PMC associated with breast cancer (BC), and to predict risk factors. METHODS: We retrospectively reviewed the medical records of 62 women with VUR, examined and treated at the Sverdlovsk Regional Oncology Center (Yekaterinburg) from 2020 to 2022. VUR associated with breast cancer was detected in 2 % of cases. Three women were excluded from the study according to the Warren–Gates criteria: two with metastases and one with mammary tuberculosis. The average time to secondary tumor detection was 5.4 years (range, 2 to 10 years). PMC was detected in the other breast in 29 % of cases, endometrial lesions were diagnosed in 17.7 % of patients, and malignant ovarian and renal neoplasms were diagnosed in 9.6 %. Disease progression in the form of metastases was observed in 14.5% of cases in patients over 55 years of age. Family history was a significant risk factor in 36 % of cases, gene mutations in 18.5 %, hormonal status in 49.4 %, obesity in 45.6 %, lymph node status in 48.4 %, previous treatment (chemotherapy or radiation therapy) in 5 %, and environmental factors in 24.5 %. A shallow learning neural network was used to predict risk factors for the development of PMC. The input data (diagnostic features) were converted to binary form: a value of “1” for a feature indicated its presence, a value of “0” indicated its absence. When training and testing the neural network, the target function was the time of secondary tumor onset and, in the presence of known breast cancer, also the time of progression. RESULTS: The risk of developing PMC within 5 years with a sensitivity of 86%, a specificity of 100 %, and an AUC of 0.929 (AUC – area under the receiver operating characteristic curve) was observed in patients over 60 years of age with stage T1–2N1 disease and luminal B and luminal/HER2-positive breast cancer (HER2 – human epidermal growth factor receptor 2). The development of PMC more than 5 years after the primary process, with a sensitivity of 64 %, a specificity of 86 %, and an AUC of 0.714, is possible in patients under 60 years of age with the luminal B molecular subtype of breast cancer and a primary tumor with a malignancy grade of G2. CONCLUSION: There is no consensus on the causes of PMC development (single tumors are not an exception). Increased survival after the onset of the first malignancy leads to an increased frequency of detection of second and subsequent tumors. Patients diagnosed with PMC, especially those with a strong family history and early onset of the disease, should be referred to a geneticist for consultation.
- Open Access
- 9 November 2025
- Published by Alfmed LLC in Medical alphabet
- No. 26,p. 7‑13
Realities and opportunities of multiple-task mammographic screening in maintaining women’s health
New applications of X-ray mammography in dispensary examinations, extending beyond traditional oncological screening, are presented. The established regulatory algorithm for breast examination is outlined, along with emerging opportunities to detect two major health issues in women– breast cancer and cardiovascular disease – through the identification of arterial wall calcifications on mammograms. The importance of early recognition of benign breast dysplasia is also emphasized, as timely pathogenetic treatment can reduce the risk of malignant transformation. By addressing multiple women’s health concerns within the framework of mammography screening, this approach improves cost-effectiveness by minimizing the need for additional facilities, equipment, staff, and patient management resources.
- 9 November 2025
- Published by Alfmed LLC in Medical alphabet
- No. 26,p. 7‑13
Open AccessRealities and opportunities of multiple-task mammographic screening in maintaining women’s health
New applications of X-ray mammography in dispensary examinations, extending beyond traditional oncological screening, are presented. The established regulatory algorithm for breast examination is outlined, along with emerging opportunities to detect two major health issues in women– breast cancer and cardiovascular disease – through the identification of arterial wall calcifications on mammograms. The importance of early recognition of benign breast dysplasia is also emphasized, as timely pathogenetic treatment can reduce the risk of malignant transformation. By addressing multiple women’s health concerns within the framework of mammography screening, this approach improves cost-effectiveness by minimizing the need for additional facilities, equipment, staff, and patient management resources.
- 27 June 2025
- Published by Media Sphere Publishing Group in Russian Journal of Preventive Medicine
- Vol. 28 (6)
Guidelines for assessing the quality of mammographic images
X-ray mammography (X-RM) is an no alternative technology for radiation diagnostics, which makes it possible to identify all known variants of non-palpable breast cancer (BC). Many years ofHigh-quality X-RM experience use during a screening procedure has proven a reduction in BC mortality during a screening procedure. The clinical effectiveness of X-ray mammography depends on the quality of the mammographic image. Objective of the recommendations. To analyze domestic and international experience in assessing the quality of X-ray mammographic images in diagnosing breast cancer and to present standards for criteria for assessing the quality of X-ray mammographic images for the use in domestic practical healthcare. Recommendations. Based on the domestic and author’s experience in BC screening, the foreign recommendations published over the past 20 years, standards for assessing breast cancer quality X-RM methods, including illustrative materials and comments to them have been agreed and proposed. Conclusion. The use of standard methods for assessing the quality of X-RM studies in the Russian practical healthcare will allow timely detection of BC and its treatment, which can prevent progression, complications of the disease as well as : progression and premature death.
- 27 June 2025
- Published by Media Sphere Publishing Group in Russian Journal of Preventive Medicine
- Vol. 28 (6)
Guidelines for assessing the quality of mammographic images
X-ray mammography (X-RM) is an no alternative technology for radiation diagnostics, which makes it possible to identify all known variants of non-palpable breast cancer (BC). Many years ofHigh-quality X-RM experience use during a screening procedure has proven a reduction in BC mortality during a screening procedure. The clinical effectiveness of X-ray mammography depends on the quality of the mammographic image. Objective of the recommendations. To analyze domestic and international experience in assessing the quality of X-ray mammographic images in diagnosing breast cancer and to present standards for criteria for assessing the quality of X-ray mammographic images for the use in domestic practical healthcare. Recommendations. Based on the domestic and author’s experience in BC screening, the foreign recommendations published over the past 20 years, standards for assessing breast cancer quality X-RM methods, including illustrative materials and comments to them have been agreed and proposed. Conclusion. The use of standard methods for assessing the quality of X-RM studies in the Russian practical healthcare will allow timely detection of BC and its treatment, which can prevent progression, complications of the disease as well as : progression and premature death.
- Open Access
- 4 December 2024
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 11 (4) , 8-22
Minimally invasive methods in pathomorphological assessment with a complete clinical response to neoadjuvant polychemotherapy in breast cancer patients
Purpose of the study. To evaluate and compare the diagnostic significance of vacuum‑ assisted biopsy (VAB) and multifocal trepan biopsy (MTB) methods based on a pathomorphological study of postoperative material in patients diagnosed with breast cancer (BC) in all molecular biological types after neoadjuvant polychemotherapy (NAPCT) with a complete clinical response (cCR). Patients and methods. The study included 70 patients with cT1–3N0–3M0 breast cancer with different molecular biological types after NAPCT. It was conducted at the P. Hertsen Moscow Oncology Research Institute – Branch of the National Medical Research Radiological Centre from 2021 to 2023. All patients underwent ultrasound and digital mammography before andafter NAPСT to assess the clinical response to treatment. MTB was performed in 35 patients, VAB in 35 patients, followed by surgical treatment. Histological findings obtained by VAB and MTB and surgical material were compared to assess the pathomorphological response of the tumor to treatment. Results. According to the pathomorphological conclusion, the following results were obtained during the VAB: 1 – truly positive, 29 – truly negative, 3 – falsely negative, 0 – falsely positive. The overall sensitivity of the technique was 25.0 % (CI 6.8–60.2 %); specificity – 100 % (CI 88.1–100 %); false negative result (presence of tumor cells in the surgical material and negative result of VAB) – 9.1 % (CI 3.4–20.2 %); false positive result (absence of tumor cells in the surgical material and a positive result of VAB) – 0 % (CI 0–10.6 %). The overall diagnostic accuracy of the method was 90.9 % (CI 79.8–96.6 %). According to the pathomorphological study, the following was obtained during the MTB: 1 – true positive, 17 – true negative, 5 – false negative and 0 – false positive results. The overall sensitivity of the technique was 16.7 % (CI: 4.3–45.9 %); specificity – (100.0 % CI: 80.5–99.9 %). The false negative result was 23.8 % (CI: 11.3–41.9 %). The false positive result is 0 %. The overall diagnostic accuracy of the method was 78.3 % (CI: 61.2–89.7 %). Conclusion. The results of the study indicate a higher sensitivity of the VAB method compared to MTB in assessing the pathomorphological response of breast cancer patients after antitumor drug treatment, which shows a vector for conducting large prospective studies of this method.
- 4 December 2024
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 11 (4) , 8-22
Open AccessMinimally invasive methods in pathomorphological assessment with a complete clinical response to neoadjuvant polychemotherapy in breast cancer patients
Purpose of the study. To evaluate and compare the diagnostic significance of vacuum‑ assisted biopsy (VAB) and multifocal trepan biopsy (MTB) methods based on a pathomorphological study of postoperative material in patients diagnosed with breast cancer (BC) in all molecular biological types after neoadjuvant polychemotherapy (NAPCT) with a complete clinical response (cCR). Patients and methods. The study included 70 patients with cT1–3N0–3M0 breast cancer with different molecular biological types after NAPCT. It was conducted at the P. Hertsen Moscow Oncology Research Institute – Branch of the National Medical Research Radiological Centre from 2021 to 2023. All patients underwent ultrasound and digital mammography before andafter NAPСT to assess the clinical response to treatment. MTB was performed in 35 patients, VAB in 35 patients, followed by surgical treatment. Histological findings obtained by VAB and MTB and surgical material were compared to assess the pathomorphological response of the tumor to treatment. Results. According to the pathomorphological conclusion, the following results were obtained during the VAB: 1 – truly positive, 29 – truly negative, 3 – falsely negative, 0 – falsely positive. The overall sensitivity of the technique was 25.0 % (CI 6.8–60.2 %); specificity – 100 % (CI 88.1–100 %); false negative result (presence of tumor cells in the surgical material and negative result of VAB) – 9.1 % (CI 3.4–20.2 %); false positive result (absence of tumor cells in the surgical material and a positive result of VAB) – 0 % (CI 0–10.6 %). The overall diagnostic accuracy of the method was 90.9 % (CI 79.8–96.6 %). According to the pathomorphological study, the following was obtained during the MTB: 1 – true positive, 17 – true negative, 5 – false negative and 0 – false positive results. The overall sensitivity of the technique was 16.7 % (CI: 4.3–45.9 %); specificity – (100.0 % CI: 80.5–99.9 %). The false negative result was 23.8 % (CI: 11.3–41.9 %). The false positive result is 0 %. The overall diagnostic accuracy of the method was 78.3 % (CI: 61.2–89.7 %). Conclusion. The results of the study indicate a higher sensitivity of the VAB method compared to MTB in assessing the pathomorphological response of breast cancer patients after antitumor drug treatment, which shows a vector for conducting large prospective studies of this method.
- Open Access
- 22 October 2024
- Published by Silicea - Poligraf, LLC in Primary Health Care (Russian Federation)
- Vol. 1 (1) , 63-80
Screening of malignant neoplasms of the breast as part of the medical examination of certain groups of the adult population. Guidelines
The Guidelines contain information on the theoretical foundations of screening for malignant neoplasms of the breast, regulatory legal acts regulating the organization of screening activities within the framework of medical examination of certain groups of the adult population, diagnostic algorithms and routing of the examined persons. Guidelines have been developed for the heads of medical organizations providing primary health care in terms of organizing processes, internists, general practitioners, medical workers from among the secondary medical personnel who are directly involved in the implementation of the process of medical examination of certain groups of the adult population.
- 22 October 2024
- Published by Silicea - Poligraf, LLC in Primary Health Care (Russian Federation)
- Vol. 1 (1) , 63-80
Open AccessScreening of malignant neoplasms of the breast as part of the medical examination of certain groups of the adult population. Guidelines
The Guidelines contain information on the theoretical foundations of screening for malignant neoplasms of the breast, regulatory legal acts regulating the organization of screening activities within the framework of medical examination of certain groups of the adult population, diagnostic algorithms and routing of the examined persons. Guidelines have been developed for the heads of medical organizations providing primary health care in terms of organizing processes, internists, general practitioners, medical workers from among the secondary medical personnel who are directly involved in the implementation of the process of medical examination of certain groups of the adult population.
- Open Access
- 7 October 2024
- Published by Luchevaya Diagnostika in Journal of radiology and nuclear medicine
- Vol. 105 (2) , 48-57
The Role of Contrast-Enhanced Imaging Methods in Breast Cancer Early Diagnostics and Treatment Planning
Оn March 27, 2023, а multidisciplinary Advisory Board meeting was held in Moscow with the participation of Е.V. Artamonova, Е.А. Busko, V.V. Didenko, А.D. Zikiryakhodzhaev, М.S. Karpova, G.Е. Kvetenadze, P.V. Krivorot’ko, М.L. Mazo, А.V. Petrovsky, О.S. Puchkova, S.V. Serebryakova under the chairmanship of I.Е. Tyurin and N.I. Rozhkova. The participants discussed different issues of early diagnostics and treatment planning of breast cancer. We present the conclusion made by the Advisory Board.
- 7 October 2024
- Published by Luchevaya Diagnostika in Journal of radiology and nuclear medicine
- Vol. 105 (2) , 48-57
Open AccessThe Role of Contrast-Enhanced Imaging Methods in Breast Cancer Early Diagnostics and Treatment Planning
Оn March 27, 2023, а multidisciplinary Advisory Board meeting was held in Moscow with the participation of Е.V. Artamonova, Е.А. Busko, V.V. Didenko, А.D. Zikiryakhodzhaev, М.S. Karpova, G.Е. Kvetenadze, P.V. Krivorot’ko, М.L. Mazo, А.V. Petrovsky, О.S. Puchkova, S.V. Serebryakova under the chairmanship of I.Е. Tyurin and N.I. Rozhkova. The participants discussed different issues of early diagnostics and treatment planning of breast cancer. We present the conclusion made by the Advisory Board.
- Open Access
- 11 September 2024
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 23 (8) , 4064
Mammographic breast density and cardiovascular disease in women. A literature review
The world is searching for new simple and economically available gender-specific markers to improve cardiovascular risk stratification in women. The aim of this review was to analyze the association of mammographic density (MD) with cardiovascular disease (CVD). In low MD, i.e., high relative mammary gland fat content, there is a higher incidence of the main risk factors for CVD: hypertension, hyperlipidemia, hyperglycemia, excess body weight, as well as an increase in the volume of fat depots, visceral and ectopic fat. Low MD is associated with a higher 10-year risk of adverse cardiovascular events such as coronary artery disease, stroke, peripheral arterial disease, revascularization, and heart failure, and may serve as a predictor of their development. Including MD in the Framingham Risk Score model improves its accuracy. Identification of low MD, as a marker of high cardiovascular risk, allows the use of mammography for early detection and prevention of the two most dangerous diseases among the female population — breast cancer and CVD.
- 11 September 2024
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 23 (8) , 4064
Open AccessMammographic breast density and cardiovascular disease in women. A literature review
The world is searching for new simple and economically available gender-specific markers to improve cardiovascular risk stratification in women. The aim of this review was to analyze the association of mammographic density (MD) with cardiovascular disease (CVD). In low MD, i.e., high relative mammary gland fat content, there is a higher incidence of the main risk factors for CVD: hypertension, hyperlipidemia, hyperglycemia, excess body weight, as well as an increase in the volume of fat depots, visceral and ectopic fat. Low MD is associated with a higher 10-year risk of adverse cardiovascular events such as coronary artery disease, stroke, peripheral arterial disease, revascularization, and heart failure, and may serve as a predictor of their development. Including MD in the Framingham Risk Score model improves its accuracy. Identification of low MD, as a marker of high cardiovascular risk, allows the use of mammography for early detection and prevention of the two most dangerous diseases among the female population — breast cancer and CVD.